DaTeBao Secures $20 Million Series B Funding to Accelerate Integration of Insurance and Healthcare

Recently, Dataibao secured $20 million in Series B financing, led by China Development Capital, the largest investment bank in Taiwan. Existing investors, including Ceyuan Ventures and Fosun, participated in the round. Following the completion of the Series B round, Dataibao’s valuation reached RMB 1 billion.

Da Te Bao was established in July 2014 as China’s first insurance service platform to hold a national insurance brokerage license for internet-based operations, with its primary offerings focused on personal health insurance. At its inception, Da Te Bao secured angel-round funding from Dewo and Xianfeng Huaxing. Within six months of its launch, it consecutively received Series A investments from leading Chinese firms, including Ceyuan Ventures, Ping An Ventures, and Fosun Group.

Primary Uses of Series B Financing

According to VCBeat, the Series B funding raised by Datebao will be primarily used for the research, development, and promotion of internet-based medical insurance, as well as for providing coverage to individuals with pre-existing conditions.

First, Da Te Bao will strive to integrate insurance with healthcare. Future insurance products will no longer be limited to claims settlement; instead, they will encompass the entire continuum of disease prevention, daily health management, and risk protection. This approach aims to reduce individuals’ disease risks and lower insurers’ claim probabilities, thereby creating a virtuous cycle. Second, it will develop insurance solutions tailored for individuals with pre-existing conditions, particularly those suffering from chronic diseases.

Currently, DataBao employs over 50 staff members, with some of its technical personnel hailing from Alibaba, Tencent, Baidu, and IBM.

Rapid Product R&D Capability

Following the exposure of the Shandong problematic vaccine incident, Da Te Bao launched “Zhen Wu You” (Needle Worry-Free), a vaccination insurance product for children. Reportedly, Da Te Bao completed the entire process—from product development and packaging design to technical implementation and market launch—within 12 hours. Daily orders exceeded 10,000.

Furthermore, Da Te Bao completed a rapid iteration to version 2.0 within two days, and on the basis of its childhood vaccination insurance, it included one complimentary telephone consultation with Dodo Doctor.

A major feature of Dataibao’s Children’s Vaccine Insurance is its industry-first inclusion of compensation for claims involving substandard vaccines, marking a precedent in the sector. Given that substandard vaccine quality falls outside the scope of national relief and compensation, illegal vaccines are excluded from commercial insurance coverage, and most vaccination-related insurance policies exempt liability for Category II vaccines, vaccine quality issues, and coincidental illnesses, Dataibao’s Vaccination Insurance covers accidental liabilities arising from the unknowing administration of expired, deteriorated, or substandard vaccines, as well as vaccines not approved by the National Medical Products Administration. This coverage includes accidental death, disability, and all resulting adverse reactions.

Currently, Da Te Bao has approximately five million users and offers more than ten health and medical insurance products. The best-selling products include child vaccination insurance, critical illness insurance for children and individuals, female breast cancer insurance, and the “Ai Xiong” insurance plan with an add-on breast cancer genetic testing service. As its earlier product launches focused on child insurance, Da Te Bao holds a distinct advantage in the research and development of insurance products for children and women.

Moreover, the strong market performance of Da Te Bao’s diabetes insurance product, “Tui Tang Gu,” has bolstered its confidence in continuing to develop products tailored for individuals with pre-existing conditions.

Da Te Bao's Growth Experience

Within just over a year of its establishment, Da Te Bao completed three rounds of financing, a rarity in the industry. Gaining recognition from the capital market also reflects Da Te Bao’s competitive strength. According to Zhou Lei, CEO of Da Te Bao, the company’s rapid growth is attributed to the following factors:

1. Focus. Only through focus can differentiated core competencies be established. Da Te Bao remains committed to deep cultivation in the field of personal health insurance, striving for excellence in products and services, and building its core competitiveness in product research and development iteration, technology implementation, big data analytics, and market promotion.

2. Inclusive for the Masses, Returning to Essentials. By offering cost-effective products and interest-free installment premium payments, health insurance is made accessible to the general public, covering those least able to withstand financial risks, thereby reaffirming the fundamental protective nature of insurance.

3. Addressing User Pain Points. Leverage the unique advantages of the internet to resolve industry and user pain points across product research and development, purchase and payment, and claims services. By prioritizing user needs, enhance service experience and build user trust.

4. Cross-industry marketing collaborations enable rapid access to target users at a relatively low cost, stimulating insurance demand in specific contexts; meeting the diverse insurance needs of different population groups has become critical. Socialized marketing is mainstream: it involves understanding where users are, establishing interactive engagement through topics widely appreciated by the public, and even involving users in product development.

5. Value-Added Services. We are committed to providing insurance that truly meets users' needs, offering value-added services for user health and medical care while fulfilling coverage requirements.

6. Do what is unique and first. The internet insurance market has enormous growth potential. Da Te Bao rejects homogenization, repeatedly filling market gaps from products to services and continuously stimulating its internal innovation capabilities.